Danaher Corporation (BMV:DHR)

Market Cap	2.69T
Revenue (ttm)	452.61B
Net Income (ttm)	64.33B
Shares Out	n/a
EPS (ttm)	88.82
PE Ratio	41.79
Forward PE	24.79
Dividend	23.88 (0.64%)
Ex-Dividend Date	Sep 26, 2025

Volume	10
Average Volume	278
Open	3,747.03
Previous Close	3,879.97
Day's Range	3,747.03 - 3,747.03
52-Week Range	3,358.00 - 5,631.00
Beta	0.80
RSI	51.58
Earnings Date	Oct 21, 2025

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. It operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides bioprocessing technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for man...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1969
• Employees: 63,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: DHR

Financial Performance

In 2024, Danaher's revenue was $23.88 billion, a decrease of -0.06% compared to the previous year's $23.89 billion. Earnings were $3.90 billion, a decrease of -17.79%.

Financial numbers in USD